Neuro 8 Flashcards
peripheral metabolism of levodopa is decreased when administered with ________________, thus increasing plasma levels, increasing half-life, thus allowing more to reach the brain
dopa-decarboxylase inhibitors (Carbidopa)
levodopa + Carbidopa decreases daily dose of levodopa by _________%
75
benefits of levodopa often diminish after __________________
3-4 years
adverse effects of levodopa
- anorexia, N/V 2. cardiac arrhythmias (tachycardia, afib) 3. postural hotn 4. behavioral effects (more common with combo therapy) 5. tardive dyskinesia
what are tardive dyskinesia sx
- grimacing 2. lip smacking 3. lip puckeringn 4. pursing of lips 5. excessive eye blinking 6. tongue smacking
80% of patients on levodopa for > 10 years will have what sx ?
tardive dyskinesia
do not give levodopa with ___________________ meds, for they reduce the effectiveness of it
phenothiazines (esp compazine)
what are your dopamine agonist drugs used in the tx of parkinsons
- pramipexole 2. ropinirole 3. rotigotine
pramipexole is a drug used with parkinsons, that has a high affinity for the __________ receptor
D3
which dopamine agonists can be used as monotherapy for parkinsons
- pramipexole 2. ropinirole
ropinirole is used in tx of parkinsons, that has a high affinity for what receptor
D2
which dopamine agonists can be used to allow the dose of levodopa to be reduced
pramipexole and ropinirole
which dopamine receptor agonists can be used in patients with advanced parkinsons dz
pramipexole and ropinirole
which dopamine agonist (in parkinsons tx) is rapidly absorbed and excreted mostly unchanged in the urine
pramipexole
which dopamine agonist for parkinsons tx is metabolized by the CYP450 system
ropinirole
what dopamine agonist in parkinsons tx is a skin patch that provides more continuous dopaminergic stimulation than oral meds in early dz
rotigotine
what is the con with rotigotine in tx of parkinsons
since it is a patch, has localized reactions at application site
adverse effects of dopamine agonists
- anorexia 2. N/V 3. constipation, dyspepsia, reflux, peptic ulcer bleeding 4. postural hotn 5. cardiac arrhythmias 6. periperhal edema 7. tardive dyskinesia 8. confusion, hallucination, and delusions
what s/e with dopamine agonists would you d/c the tx
cardiac arrhythmias
what meds other than dopamine agonists, levodopa, and carbidopa can be used in parkinsons (sx) tx?
- MAOI (selegiline & rasagiline [more potent]) 2. catechol-o-methytransferase inhibitors (tolcapone & entacapone) 3. apomorphine hydrochloride 4. acetycholine blockers
toxicity of chlorpromazine (Thorazine)
- extension of effects of alpha and muscarinic blockade 2. block of dopa R –> akathisia, dystonia, parkinsonian sx, TD, and hyperprolactinemia
effects of chlorpromazine
- alpha blocker 2. muscarinic blocker 3. H1 blocker 4. CNS depression 5. decreases seizure threshold
MOA of haloperidol
blockage of D2»_space; 5HT2a
effects of haloperidol
- some alpha blockade 2. minimimal M blockade 3. much less sedation than phenothiazines (chlorpromazine)
clinical applications of haloperidol
- schizophrenia (alleviates positive sx) 2. bipolar (manic phase) 3. huntingtons dz 4. tourrettes
s/e of haloperidol
- extrapyramidal dysfunction
Clozapine MOA
blockade of 5-HT2a receptors > D2 block
effects of Clozapine
- some alpha blockade 2. some M blockade 3. variable H1 block
clinical applications of clozapine
- schizophrenia (+ and - sx) 2. agitation in alzheimers & parkinsons
s/e with clozapine
- agranulocytosis 2. DM 3. hypercholesterolemia 4. weight gain
effects of lithium (as antipsychotic)
- no significant antagonistic actions on ANS R or specific CNS receptors 2. no sedation
clinical application of lithium
- bipolar affective d/o 2. prophylactic use can prevent mood swings btwn mania and depression 3. depression
s/e (toxicity) of lithium
- tremor 2. edema 3. hypothyroidism 4. renal dysfx 5. dysrhythmias 6. pregnancy category D
clearance of lithium is decreased by _______________ and some __________
thiazides; NSAIDs
MOA of carbamazepine as an antipsychotic
MOA unclear for bipolar
effects of carbamazepine
dose-related diplopia and ataxia
clinical application of carbamazepine
- acute mania 3. prophylaxis of mania in depressive stage of bipolar
s/e of carbamazepine
- hematotoxicity 2. induction of CYP450 metabolism